Einde inhoudsopgave
Principles of European Law on Service Contracts (PELSC)
Artikel 7:105 Duty to Inform of the Treatment Provider
Geldend
Geldend vanaf 01-10-2005
- Redactionele toelichting
De dag van de datum van publicatie is gezet op 01.
- Bronpublicatie:
01-10-2005, Internet 2005, www.sgecc.net (uitgifte: 01-10-2005, kamerstukken/regelingnummer: -)
- Inwerkingtreding
01-10-2005
- Bronpublicatie inwerkingtreding:
01-10-2005, Internet 2005, www.sgecc.net (uitgifte: 01-10-2005, kamerstukken/regelingnummer: -)
- Vakgebied(en)
Verbintenissenrecht / Overeenkomst
(1)
The treatment provider must, in order to give the patient a free choice regarding treatment, and in a way understandable to the patient, in particular inform the patient about:
- (a)
the patient's health status;
- (b)
the nature of the proposed treatment;
- (c)
the advantages of the proposed treatment;
- (d)
the risks of the proposed treatment;
- (e)
the alternatives to the proposed treatment as well as their advantages and risks as compared to those of the proposed treatment; and
- (f)
the consequences of abstaining from any treatment.
(2)
The treatment provider must, in any case, inform the patient about any risk or alternative that may reasonably influence the patient's decision on whether to give consent to the proposed treatment or not. A risk is presumed to be capable of influencing that decision if its materialisation leads to serious detriment to a patient in that situation. Unless otherwise provided, the duty to inform is subject to the provisions of Chapter 6 (Information).